Quince Therapeutics (QNCX) Stock Chart & Stock Price History $2.04 -0.01 (-0.49%) (As of 12/12/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Quince Therapeutics Stock Price Performance 5 Day Performance-2.86%1 Month Performance+21.43%3 Month Performance+177.55%6 Month Performance+185.31%Year-To-Date Performance+94.29%1 Year Performance+104.18% Receive QNCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now QNCX Stock Chart for Thursday, December, 12, 2024 QNCX Chart by TradingView Quince Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/11/2024$1.97$2.05+4.06%$2.11$1.94184,980 shs$90.20 million12/10/2024$2.04$1.97-3.43%$2.15$1.91151,984 shs$86.68 million12/09/2024$2.10$2.04-2.86%$2.45$1.99464,812 shs$89.76 million12/06/2024$1.82$2.10+15.38%$2.17$1.76298,604 shs$92.40 million12/05/2024$2.00$1.82-9.00%$2.05$1.69564,132 shs$80.08 million12/04/2024$2.16$2.00-7.41%$2.14$1.98234,092 shs$88 million Get the Latest News and Ratings for QNCX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/03/2024$2.08$2.16+3.85%$2.19$2.02227,493 shs$91.52 million12/02/2024$2.05$2.08+1.46%$2.15$1.96184,695 shs$91.52 million11/29/2024$2.04$2.05+0.49%$2.08$2.0058,641 shs$90.20 million11/28/2024$2.04$2.04$2.11$2.0295,284 shs$89.76 million11/27/2024$2.02$2.04+0.99%$2.11$2.0292,009 shs$89.76 million11/26/2024$1.98$2.02+2.02%$2.14$2.00295,061 shs$88.88 million11/25/2024$1.96$1.98+1.02%$2.21$1.95527,645 shs$87.12 million11/22/2024$2.08$1.96-5.77%$2.45$1.681.05 million shs$86.24 million11/21/2024$1.84$2.08+13.04%$2.14$1.80312,412 shs$91.52 million11/20/2024$1.77$1.84+3.95%$1.87$1.77139,936 shs$80.96 million11/19/2024$1.75$1.77+1.14%$1.85$1.71123,904 shs$77.88 million11/18/2024$1.78$1.75-1.69%$1.88$1.71182,325 shs$77 million11/15/2024$1.90$1.78-6.32%$2.14$1.621.01 million shs$77.04 million11/14/2024$1.59$1.90+19.50%$1.95$1.56568,755 shs$82.23 million11/13/2024$1.68$1.59-5.36%$1.73$1.58233,576 shs$68.82 million11/12/2024$1.66$1.68+1.20%$1.71$1.53319,926 shs$72.71 million11/11/2024$1.70$1.66-2.35%$1.76$1.62286,480 shs$71.84 million Related Companies Aquestive Therapeutics Stock Price Chart Tango Therapeutics Stock Price Chart uniQure Stock Price Chart Kamada Stock Price Chart Foghorn Therapeutics Stock Price Chart Voyager Therapeutics Stock Price Chart Valneva Stock Price Chart Neurogene Stock Price Chart Jasper Therapeutics Stock Price Chart Amylyx Pharmaceuticals Stock Price Chart Receive QNCX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Quince Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:QNCX) was last updated on 12/12/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThis could bring inflation roaring back (I’m concerned)"For AI... We have to produce massive electricity that we don't have. Nuclear has become very safe, very good....The Oxford Club | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCaught on camera (shocking new AI tech)Everyone is talking about the “Magnificent Seven"... Nvidia, Meta, Google, Microsoft, etc. Meanwhile, they ...Banyan Hill Publishing | SponsoredThis happened before the 1987 crash too…I’d urge you to watch my latest exposé into what’s really going on in the tech sector… why I believe we could ...Porter & Company | SponsoredPrepare Now Before This Looming $2 Trillion D.C. ShockMillions of traders could get blindsided by this election-year shock on December 18th… And if you do nothin...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quince Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Quince Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.